What is the best treatment for ovarian hyperstimulation syndrome (OHSS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ovarian Hyperstimulation Syndrome (OHSS)

The best treatment for ovarian hyperstimulation syndrome (OHSS) involves careful monitoring of fluid balance, intravenous crystalloids for intravascular volume replacement, thromboprophylaxis with LMWH, and paracentesis for severe ascites. 1

Classification and Initial Management

OHSS severity determines the treatment approach:

  • Mild OHSS: No specific treatment required, outpatient monitoring
  • Moderate OHSS: Outpatient follow-up with supportive care
  • Severe OHSS: Requires comprehensive evaluation and intervention

Management Protocol for Severe OHSS

1. Monitoring Parameters (Daily)

  • Weight
  • Abdominal circumference
  • Urine output
  • Vital signs
  • Complete blood count
  • Electrolytes
  • Liver and renal function tests
  • Coagulation profile 1

2. Fluid Management

  • Intravenous crystalloids (normal saline) for intravascular volume replacement
  • Albumin administration may be considered in severe cases, though evidence shows only borderline benefit (OR 0.67,95% CI 0.45 to 0.99) 2
  • Hydroxyethyl starch shows more significant reduction in severe OHSS (OR 0.12,95% CI 0.04 to 0.40) 2
  • Avoid diuretics as they may further contract intravascular volume 3

3. Thromboprophylaxis

  • LMWH prophylaxis (enoxaparin 40 mg daily) is recommended for severe OHSS 1
  • Begin at the start of ovarian stimulation
  • Withhold 24-36 hours before oocyte retrieval
  • Resume after retrieval
  • Continue until estrogen levels return to near-physiologic levels if no pregnancy occurs 1

4. Paracentesis

  • Indicated for:
    • Severe ascites causing respiratory compromise
    • Significant discomfort
    • Oliguria despite adequate fluid replacement
  • Can be performed transvaginally or transabdominally
  • May prevent need for hospitalization in moderate-severe cases 1
  • Results in marked symptom improvement, improved diuresis, and shortened hospital stay 3

Outpatient vs. Inpatient Management

Recent evidence supports outpatient management for selected patients with severe OHSS:

  • Must have appropriate outpatient setup and protocols
  • Includes paracentesis of ascitic fluid and supportive management
  • Found to be safe and cost-effective compared to inpatient management 4

Intensive Care Admission Criteria

  • Severe respiratory distress
  • Major electrolyte imbalance
  • Elevated serum creatinine
  • Thromboembolic complications
  • Refractory oliguria/anuria 3

Common Pitfalls and Caveats

  1. Delayed recognition of complications: Monitor for thromboembolism, which can occur up to 11 weeks after initial presentation 1

  2. Inadequate thromboprophylaxis: Patients with antiphospholipid syndrome or history of thrombosis require therapeutic anticoagulation rather than prophylactic doses 1

  3. Inappropriate use of diuretics: Generally contraindicated as they may worsen intravascular volume depletion 3

  4. Overlooking outpatient management options: Paracentesis can significantly improve symptoms and may prevent hospitalization in appropriate cases 4

  5. Inadequate monitoring: Daily assessment of fluid balance, weight, abdominal circumference, and laboratory parameters is essential 1

References

Guideline

Ovarian Hyperstimulation Syndrome (OHSS) Prevention and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.

The Cochrane database of systematic reviews, 2011

Research

Treatment of ovarian hyperstimulation syndrome.

Seminars in reproductive medicine, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.